mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes

Individuals with primary antibody deficiency (PAD) syndromes have poor humoral immune responses requiring immunoglobulin replacement therapy. We followed individuals with PAD after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination by evaluating their immunoglobulin replacement...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmerman, Ofer, Altman Doss, Alexa Michelle, Kaplonek, Paulina, Liang, Chieh-Yu, VanBlargan, Laura A., Chen, Rita E., Monroy, Jennifer Marie, Wedner, H. James, Kulczycki, Anthony, Mantia, Tarisa L., O’Shaughnessy, Caitlin C., Davis-Adams, Hannah G., Bertera, Harry L., Adams, Lucas J., Raju, Saravanan, Zhao, Fang R., Rigell, Christopher J., Dy, Tiffany Biason, Kau, Andrew L., Ren, Zhen, Turner, Jackson S., O’Halloran, Jane A., Presti, Rachel M., Fremont, Daved H., Kendall, Peggy L., Ellebedy, Ali H., Alter, Galit, Diamond, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179023/
https://www.ncbi.nlm.nih.gov/pubmed/35688161
http://dx.doi.org/10.1016/j.xcrm.2022.100653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179023/
https://www.ncbi.nlm.nih.gov/pubmed/35688161
http://dx.doi.org/10.1016/j.xcrm.2022.100653

Ejemplares similares